Regenerative Medical Technology (RMTG) Revenue (2018 - 2026)

Regenerative Medical Technology has reported Revenue for 9 years, with the latest figure at $4.0 million in Q2 2026.

• On a quarterly basis, Revenue rose 309.1% year-over-year to $4.0 million in Q2 2026; TTM through Jun 2026 was $9.4 million, a 94.32% increase from a year earlier, with the FY2025 full-year figure at $5.1 million, up 24.17% from the prior year.
• Revenue was $4.0 million for Q2 2026 at Regenerative Medical Technology, up from $2.6 million in the prior quarter.
• The five-year high for Revenue was $4.0 million in Q2 2026, with the low at $297522.0 in Q2 2022.
• Average Revenue over 5 years is $1.1 million, with a median of $805181.5 recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Revenue surged 6624.02% in 2022, then increased 3.92% in 2024.
• Over 5 years, Revenue stood at $566256.0 in 2022, then grew by 8.71% to $615568.0 in 2023, then soared by 145.44% to $1.5 million in 2024, then gained by 4.04% to $1.6 million in 2025, then soared by 155.91% to $4.0 million in 2026.
• The last three Revenue figures came in at $4.0 million (Q2 2026), $2.6 million (Q1 2026), and $1.6 million (Q4 2025), per Business Quant data.